GENE ONLINE|News &
Opinion
Blog

Deals
Roivant Inks $450 Million Worth Drug Discovery Deal with Silicon Therapeutics
2021-02-28
Clover Biopharmaceuticals Raises $230 Million to Expand Trimer-Tag Technology
2021-02-28
Orna Therapeutics Brings to Market New Therapy to Treat Cancer and Other Diseases
2021-02-26
Merck Acts on its Post-Keytruda Plan, Spends $1.85B to Acquire Pandion for Autoimmune Therapies
2021-02-26
Beam Therapeutics Acquires Georgia Tech Spin Out, Seeks Non-Viral Gene Therapy Delivery Vehicles
2021-02-25
Charles River Labs Expands Manufacturing Capabilities Through CDMO Acquisition
2021-02-23
Durham-Based Regenerative Medicine Company, Humacyte Joins Expanding List of Biotech SPACs
2021-02-21
BIOCEO21 Highlights: Criteria for Successful Launches of Biotech SPACs
2021-02-21
BIOCEO21: Scientists and Investors Weigh on Pioneering Innovations and Investments in Oncology
2021-02-18
Texas Biopharma Inks $1.3 Billion Worth BMS Deal to Develop Engineered Toxin Bodies
2021-02-14
Pacific Biosciences Secures 900 Million Investment to Advance Gene Sequencing
2021-02-13
Ensoma Enters Gene-Editing Market with $70 Million Funding and Takeda Partnership
2021-02-12
Proteomics Company Nautilus Bio to List on NASDAQ via SPAC
2021-02-12
IPO
Vor BioPharma Surpasses $1 Billion Valuation After IPO
2021-02-07
Sana Biotechnology Makes Wall Street Debut with $587.5 Million IPO
2021-02-05
1 35 36 37 38 39 47
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
EVENT
Scroll to Top